Wire Stories

Brii Biosciences Monoclonal Antibodies, BRII-196 and BRII-198, Progress to Phase 3 in NIH ACTIV-2 Trial in Ambulatory COVID-19 Patients

Independent data safety monitoring board (DSMB) formally recommends investigational combination therapy advance to Phase 3 following Phase 2 pre-specified analysis…

5 years ago

Coupang to Announce First Quarter 2021 Results on May 12, 2021

SEOUL, South Korea--(BUSINESS WIRE)--$CPNG--Coupang, Inc. (NYSE: CPNG) will release its financial results for its first quarter ended March 31, 2021…

5 years ago

Mirum Pharmaceuticals and CANbridge Pharmaceuticals Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat in Greater China for Rare Liver Diseases

- CANbridge to lead development and commercialization in China; expands rare disease pipeline - Mirum is entitled to receive up…

5 years ago

Embassy REIT Announces Full Year FY 2021 Results, Delivers a Resilient Performance

Distributes Rs 18,364 million and grows Net Operating Income YoY by 12% Leases 1.2 msf across 40+ deals, achieves 15%…

5 years ago

Asia-Pacific Specialty Chemicals Market (2020 to 2027) – Trend Outlook and Growth Opportunity – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Specialty Chemicals Market 2020-2027 by Application (Construction, Food & Feed, Pharmaceutical & Cosmetic, Water Treatment, Paper &…

5 years ago

APAC Pharmaceutical Manufacturing Industry to 2027 – by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility & Country – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel,…

5 years ago

Tradeshift Appoints James Stirk as Head of Enterprise Sales for EMEA & APAC Regions

Stirk brings 25 years� experience driving sales growth for some of the world�s most successful enterprise technology businesses LONDON--(BUSINESS WIRE)--#accountspayable--Tradeshift,…

5 years ago

Pre-clinical data for Celltrion�s monoclonal antibody treatment regdanvimab (CT-P59) shows significant reduction in viral load of SARS-CoV-2, with no significant…

5 years ago

Standard Protocol joins forces with DEXTools to set a new standard for digital assets

SINGAPORE--(BUSINESS WIRE)--Standard Protocol � a Polkadot-based Collateralized Rebasable Stablecoin (CRS) protocol for synthetic assets � has established a strategic partnership…

5 years ago

Janus Henderson Group plc Reports First Quarter 2021 Diluted EPS of US$0.88, or US$0.91 on an Adjusted Basis

Solid long-term investment performance, with 62% and 70% of assets under management (�AUM�) outperforming relevant benchmarks on a three- and…

5 years ago